Trump Sides With Tobacco Industry in Vape Dispute
President Trump intervened in a regulatory dispute over vaping products, supporting tobacco companies against a position held by his own administration's officials. The Food and Drug Administration commissioner resigned in protest following the decision. The New York Times reported the tobacco industry had contributed to groups supporting Trump.
rediff.comOne official, the FDA commissioner, resigned in protest after the intervention. The tobacco companies involved had contributed to groups affiliated with Trump. Officials at the FDA had been advancing restrictions on certain vaping products before the president's involvement.
The action marks a direct intervention by the president in an ongoing regulatory process at the agency. It remains unclear how the decision will alter specific rules on vape sales or marketing. The resignation of the commissioner followed the resolution of the dispute in favor of the industry position.
Tobacco companies provided financial support to groups connected to Trump ahead of the regulatory decision. No specific amounts or timing details beyond the general connection were provided in the reporting. The FDA had been examining measures that could have tightened controls on vaping devices and liquids.
Industry representatives had opposed those measures. Trump's decision aligned with the companies' objections rather than the agency's earlier direction.
Key Facts
Story Timeline
3 events- 2026-05-14
The New York Times reported President Trump sided with tobacco companies in a vape dispute.
1 sourceThe New York Times - Recent days
FDA commissioner resigned in protest after the president's intervention.
1 sourceThe New York Times - Prior months
Tobacco companies contributed to groups supporting Trump.
1 sourceThe New York Times
Potential Impact
- 01
Tobacco companies may face fewer restrictions on vaping product sales.
- 02
The FDA could experience internal leadership changes following the resignation.
- 03
Regulatory timeline for vaping rules may be delayed or altered.
- 04
Public debate over political contributions and regulatory decisions may increase.
Transparency Panel
Related Stories
thehindu.comTrump Administration Seeks Next FDA Commissioner to Rebuild Trust and Advance Reforms
The administration is moving quickly to find a successor after FDA Commissioner Marty Makary resigned on Tuesday. Officials want the next leader to rebuild trust with agency staff, emphasize food policy and continue drug-approval reforms. The search is expected to take several we…
StatNYU Langone Receives Federal Grand Jury Subpoena on Gender-Affirming Care for Minors
NYU Langone Health disclosed last week that it received a grand jury subpoena from the U.S. Attorney’s Office in the Northern District of Texas seeking records on minors who received gender-affirming care from 2020 to 2026. The request marks a shift from prior administrative subp…
nbcnews.comKennedy Spokesman Resigns Over Flavored E-Cigarette Policy
A spokesman for the Kennedy organization resigned in a letter to President Trump. The official opposed a decision to permit the sale of flavored e-cigarettes, stating it would increase their appeal to children. The New York Times reported the resignation on May 13, 2026.